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Continual improvement and targeting of large animal
models with contemporary technology augment their
accuracy and value. New discoveries within the models
contribute to reliable results with reduced variability.
Despite the importance of large animal stem cell
models to biomedical advances, the knowledge base
surrounding them is relatively limited compared with
that of human and rodents. The series of investigations
presented by Niada and colleagues helps to meet this
essential element of large animal models with
information about in vitro behavior of porcine adipose-
derived stem cells from two different harvest sites as
well as their responses to implant materials and
porcine serum.tion that animal models are central to veterinary andLarge animal models of human musculoskeletal and
dental disorders are invaluable to preclinical safety and
efficacy testing prior to advancing novel therapies to
clinical trials. The article by Niada and colleagues [1] in
a recent issue of Stem Cell Research & Therapy provides
information about in vitro behavior of adipose-derived
stem cells (ASCs) from two different harvest sites in a
porcine model. Effects of implant materials, titanium
and silicon carbide coating, on ASC osteogenesis and
porcine serum on cell proliferation are also assessed.
Animal model validation that includes thorough
characterization of the proposed therapy and confirms
accuracy for the target clinical condition is critical to
outcome information that benefits human and veterinary
patients [2]. The results of the studies described in the
article impact future studies in the area by contributing
to the current understanding of porcine ASCs from a
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2014The pig is an established animal model for dental, oral,
and maxillofacial research and preclinical testing. In fact,
it is a model of choice for novel implant design testing
for a number of reasons [3]. Porcine bone anatomy,
morphology, healing, and remodeling are similar to
those of humans [4]. The rate of bone regeneration in
pigs (1.2-1.5 mm/day) is reportedly closer to that in
humans (1.0-1.5 mm/day) than dogs (1.5-2.0 mm/day)
[3]. Deciduous and permanent tooth morphology and
periodontal tissue anatomy of miniature pigs are similar
to those of humans [5]. Porcine models are a major
focus of regenerative medicine studies using stem cells
harvested from numerous harvest sites, including adi-
pose tissue [6]. Although there are recognized limita-
tions of animal models for human conditions from
unavoidable differences among species, there is no ques-
human medical advances. Focused research efforts to im-
prove upon the models will increase the value and poten-
tial impact of data derived from studies that use them.
Characterization of ASCs from distinct adipose tissue
harvest sites is vital to clinical translation of the tech-
nology. Adipose tissue harvested during elective lipo-
suction is a common source of ASCs for autologous
administration [7]. However, the procedure is not neces-
sarily practical for all patients. Additionally, adipose
tissue deposition varies in ASC quality and quantity
among depots in the same individual and for the same
depot between individuals, human and animal [1,8].
Current knowledge supports the view that ASCs iso-
lated from orthotopic locations may have advantages
over those isolated from tissue distant to the treatment
site [9]. Differences in ASC behavior among species
also limit extrapolation of information among them
[8]. It is therefore critical to carefully characterize and
identify species- and depot-specific ASCs to appro-
priately qualify results and conclusions. This is also im-
portant for generation of species-compatible implants to
avoid xenograft complications. Studies such as that by
Niada and colleagues address several of these impor-
tant issues.e licensee has exclusive rights to distribute this article, in any medium, for 12
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deration for Adipose Therapeutics and Science and the
International Society for Cellular Therapy provides min-
imal criteria to define stromal vascular fraction cells and
ASCs [7]. Basic characterization of cultured ASCs in-
cludes phenotyping with flow cytometry and confir-
mation of the ability of the cells to differentiate into
osteoblastic, chondrocytic, and adipocytic lineages.
Current standards support confirmation of cell differen-
tiation using target gene and protein expression quanti-
tation versus histochemical analysis. The study by Niada
and colleagues incorporates many of the recommenda-
tions. Unfortunately, passage 4 cells tested with mono-
clonal antibodies against CD14, CD45, CD73, CD90,
CD105, and CD271 showed that cells were CD90+,
CD271−, CD45−, and CD14−. There was no cross-
reactivity of the CD73 and CD105 antibodies. Shortages
of monoclonal antibodies directed against animal cell
surface markers can limit the ability to determine stem
cell phenotype in large animal models [10]. When it is
necessary to use non-species-specific antibodies, con-
firmation of reactivity with the target species protein is
necessary for valid results. Standardized, rigorous, and
consistent phenotyping of ASCs in animal models is
critical to robust results that support repeatability and
the greatest potential for application across species.
In vitro knowledge of interactions between stem cells
and implant materials is required to anticipate the
in vivo response of exogenous and native stem cells.
In vitro culture conditions that closely mimic the na-
tural environment of the clinical target site provide
valuable insight for preclinical models. Porcine ASCs
cultured on titanium, silicon carbide coating, and
plastic were evaluated for total protein concentration
and calcium-rich deposits after 21 days of culture in
osteogenic or basal medium in the study. Based on
staining, there was greater deposition by ASCs on ti-
tanium discs compared with plastic when cultured in
both basal and osteogenic media. Total protein levels
were less supportive of differences among culture
surfaces. A more in-depth evaluation of porcine ASC
osteogenic differentiation on implant materials that
includes protein and gene expression at several time
points will provide opportunities for detailed compa-
risons among parallel studies with ASCs from diffe-
rent species as well as among investigations using
porcine models [11].
Alternatives to fetal bovine serum (FBS) supplementa-
tion of basal medium for ex vivo expansion of stem cells
are an area of significant interest. Despite efforts to
characterize FBS, there is variability among preparations,
and there is always the potential for xenogeneic proteins
to affect cell behavior [12]. Quality and safety of stem cells
intended for therapeutic application will be enhanced byexpansion under xeno-free conditions. Results from por-
cine ASCs cultured in heterologous or homologous serum
do not support use of species-specific serum in the study
by Niada and colleagues. However, serum quality com-
pounded by a relatively low concentration in the medium
may have impacted the outcomes. Outcomes were limited
to cell proliferation and morphology in basal medium con-
taining 5% heterologous or homologous porcine serum or
10% FBS. Other studies suggest that higher levels of adult
serum are necessary to support the same in vitro cell be-
havior observed at lower FBS levels [13]. Continued, in-
depth efforts toward development of xeno-free culture
conditions are crucial to continued progress in this area.
Optimization of preclinical animal models facilitates
design and implementation of regenerative therapies,
and porcine models are established for a large number
of oromaxillary and dental procedures. Harvest of ASCs
from the buccal fat pad for orthotopic administration is
a logical extension of current surgical procedures. Infor-
mation about porcine buccal fat pad ASCs is limited
despite the model’s importance to continued medical
advances in the area. Differences among adipose tissue
depots and species require individual characterization of
ASCs among them. The results of the study by Niada
and colleagues contribute to the current understanding
of porcine buccal adipose tissue ASCs to support future
investigations in this important animal model.
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